特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
962951

神経痛治療の世界市場:治療別、エンドユーザー別および地域別予測による市場規模の調査(2020年~2027年)

Global Neuralgia Treatment Market Size study, by Treatment (Drug Based, Surgery), by End-User (Hospitals & Clinics, Ambulatory Surgery Center, Others) and Regional Forecasts 2020-2027

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.45円
神経痛治療の世界市場:治療別、エンドユーザー別および地域別予測による市場規模の調査(2020年~2027年)
出版日: 2020年10月01日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の神経痛治療の市場規模は2019年に約18億米ドルであり、2020年から2027年の予測期間にわたって6%を超える成長率で成長すると予想されています。神経痛は、神経の損傷または炎症により、激しい痛みを引き起こすことです。神経痛の治療手順は、糖尿病、心血管疾患など、神経の損傷によって引き起こされる障害を治療するのに役立つ効果的な治療であることが証明されています。神経痛治療法には、圧を和らげるための手術、糖尿病患者の血中の糖レベルの調節、理学療法、痛みを軽減するための硬膜外注射などがあります。さらに、神経痛治療市場の拡大は、より良い診断基準オプションの存在と神経痛治療サービスへのアクセスが世界中で絶え間なく拡大しているという事実に大きく帰属しています。さらに、世界中の高齢者人口の増加に伴う糖尿病と三叉神経痛の有病率の上昇は、予測期間中の市場のCAGRに関与する要因の一つです。国際糖尿病連合(IDF)によると、2019年には世界中で20~79歳の成人が4億6,300万人、糖尿病を患っており、この数は2045年までに約7億人に達する可能性があります。これにより、神経痛治療の需要が高まり、世界中の市場成長が加速することが期待されます。ただし、熟練したヘルスケア専門家の不足や治療の高コストは、2020年から2027年の予測期間にわたって市場の成長を抑制する可能性がある要因の一つです。

当レポートでは、神経痛治療市場を調査し、市場概要、市場の成長要因および阻害要因の分析、治療別・エンドユーザー別・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイル、市場機会など、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の神経痛治療市場の定義と範囲

第3章 世界の神経痛治療市場力学

  • 神経痛治療市場の影響分析

第4章 世界の神経痛治療市場業界分析

  • ポーターの5フォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論

第5章 世界の神経痛治療市場:治療別

  • 市場スナップショット
  • 世界の神経痛治療市場-潜在的な分析:治療、性能別
  • 世界の神経痛治療市場の見積もりと予測(2017年-2027年):治療別
  • 神経痛治療市場:サブセグメント分析
    • 薬物ベース
    • 手術

第6章 世界の神経痛治療市場:エンドユーザー別

  • 市場スナップショット
  • 世界の神経痛治療市場-潜在的な分析:エンドユーザー別
  • 世界の神経痛治療市場の見積もりと予測(2017年-2027年):エンドユーザー別
  • 神経痛治療市場:サブセグメント分析
    • 病院とクリニック
    • 外来手術センター
    • その他

第7章 世界の神経痛治療市場:地域別分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • 中南米スナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第8章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • GlaxoSmithKline PLC
    • Pfizer Inc.
    • Novartis AG
    • Biogen Inc.
    • Cadila Healthcare Limited
    • Lundbeck Pharmaceuticals LLC
    • Allergan Plc
    • Merz Pharma GmbH & Co.
    • Trigemina Inc.,
    • Abbott Laboratories

第9章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Neuralgia Treatment market, report scope
  • TABLE 2. Global Neuralgia Treatment market estimates & forecasts by region 2017-2027 (USD Billion)
  • TABLE 3. Global Neuralgia Treatment market estimates & forecasts by Treatment 2017-2027 (USD Billion)
  • TABLE 4. Global Neuralgia Treatment market estimates & forecasts by End-User 2017-2027 (USD Billion)
  • TABLE 5. Global Neuralgia Treatment market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 6. Global Neuralgia Treatment market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 7. Global Neuralgia Treatment market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 8. Global Neuralgia Treatment market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 9. Global Neuralgia Treatment market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 10. Global Neuralgia Treatment market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 11. Global Neuralgia Treatment market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 12. Global Neuralgia Treatment market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 13. Global Neuralgia Treatment market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 14. Global Neuralgia Treatment market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 15. Global Neuralgia Treatment market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 16. Global Neuralgia Treatment market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 17. Global Neuralgia Treatment market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 18. Global Neuralgia Treatment market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 19. Global Neuralgia Treatment market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 20. Global Neuralgia Treatment market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 21. U.S. Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 22. U.S. Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 23. U.S. Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 24. Canada Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 25. Canada Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 26. Canada Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 27. UK Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 28. UK Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 29. UK Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 30. Germany Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 31. Germany Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 32. Germany Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 33. France Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 34. France Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 35. France Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 36. Spain Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 37. Spain Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 38. Spain Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 39. Italy Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 40. Italy Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 41. Italy Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 42. ROE Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 43. ROE Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 44. ROE Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 45. China Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 46. China Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 47. China Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 48. India Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 49. India Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 50. India Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 51. Japan Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 52. Japan Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 53. Japan Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 54. Australia Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 55. Australia Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 56. Australia Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 57. South Korea Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 58. South Korea Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 59. South Korea Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 60. ROPAC Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 61. ROPAC Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 62. ROPAC Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 63. Brazil Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 64. Brazil Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 65. Brazil Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 66. Mexico Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 67. Mexico Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 68. Mexico Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 69. ROLA Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 70. ROLA Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 71. ROLA Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 72. ROW Neuralgia Treatment market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 73. ROW Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 74. ROW Neuralgia Treatment market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 75. List of secondary sources, used in the study of global Neuralgia Treatment market
  • TABLE 76. List of primary sources, used in the study of global Neuralgia Treatment market
  • TABLE 77. Years considered for the study
  • TABLE 78. Exchange rates considered

LIST OF FIGURES

  • FIG 1. Global Neuralgia Treatment market, research methodology
  • FIG 2. Global Neuralgia Treatment market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Neuralgia Treatment market, key trends 2019
  • FIG 5. Global Neuralgia Treatment market, growth prospects 2020-2027
  • FIG 6. Global Neuralgia Treatment market, porters 5 force Model
  • FIG 7. Global Neuralgia Treatment market, pest analysis
  • FIG 8. Global Neuralgia Treatment market, value chain analysis
  • FIG 9. Global Neuralgia Treatment market by segment, 2017 & 2027 (USD Billion)
  • FIG 10. Global Neuralgia Treatment market by segment, 2017 & 2027 (USD Billion)
  • FIG 11. Global Neuralgia Treatment market by segment, 2017 & 2027 (USD Billion)
  • FIG 12. Global Neuralgia Treatment market by segment, 2017 & 2027 (USD Billion)
  • FIG 13. Global Neuralgia Treatment market by segment, 2017 & 2027 (USD Billion)
  • FIG 14. Global Neuralgia Treatment market by segment, 2017 & 2027 (USD Billion)
  • FIG 15. Global Neuralgia Treatment market by segment, 2017 & 2027 (USD Billion)
  • FIG 16. Global Neuralgia Treatment market by segment, 2017 & 2027 (USD Billion)
  • FIG 17. Global Neuralgia Treatment market, regional snapshot 2017 & 2027
  • FIG 18. North America Neuralgia Treatment market 2017 & 2027 (USD Billion)
  • FIG 19. Europe Neuralgia Treatment market 2017 & 2027 (USD Billion)
  • FIG 20. Asia-Pacific Neuralgia Treatment market 2017 & 2027 (USD Billion)
  • FIG 21. Latin America Neuralgia Treatment market 2017 & 2027 (USD Billion)
  • FIG 22. Global Neuralgia Treatment market, company market share analysis (2019)
目次

Global Neuralgia Treatment Market is valued approximately at USD 1.8 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 6% over the forecast period 2020-2027. Neuralgia is an anomalous symptom which causes intense and mostly severe pain, due to damaged or irritated nerve. Neuralgia treatment procedures are proven to be an effective treatment option, which helps to cure disorders caused by the damages nerve, including diabetes, cardiovascular diseases, and many more. Potential neuralgia treatment methods may include surgery to ease the pressure, regulate sugar level in the blood of diabetic patient, physical therapy, epidural injections to reduce pain, etc., which ultimately expand the scope of neuralgia treatment around the world. Further, the increase in the neuralgia treatment market is significantly imputed to the fact that the presence of better diagnostic criteria options and access to neuralgia treatment service is relentlessly expanding across the globe. Moreover, the rise in prevalence of diabetes and trigeminal neuralgia along with growing geriatric population around the world are the few other factors responsible for the CAGR of the market during the forecast period. According to the International Diabetic Federation (IDF), there were 463 million adults aged between 20-79 years are living with diabetes in 2019 worldwide, and this prevalence is likely to reach at almost 700 million by the year 2045. Likewise, as per the IDF Diabetes Atlas in 2019, the numbers of diabetic patients in Europe is likely to reach around 68 million by the year 2045, and the total health expenditure for the treatment of diabetes is valued at USD 214 billion. This, in turn, is expected to strengthen the demand for neuralgia treatment, accelerating the market growth all over the world. However, the high cost of the treatment coupled with the lack of skilled healthcare professionals are the few factors restraining the market growth over the forecast period of 2020-2027.

The regional analysis of the global Neuralgia Treatment market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the growing awareness among people for neuralgia treatment along with the presence of a significant number of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in prevalence of diabetes and neuralgia disorder followed by the growing aging population in the countries, such as China and India, would create lucrative growth prospects for the Neuralgia Treatment market across the Asia-Pacific region.

Major market player included in this report are:

GlaxoSmithKline PLC

Pfizer Inc.

Novartis AG

Biogen Inc.

Cadila Healthcare Limited

Lundbeck Pharmaceuticals LLC

Allergan Plc

Merz Pharma GmbH & Co.

Trigemina Inc.,

Abbott Laboratories

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment:

Drug Based

Surgery

By End-User:

Hospitals & Clinics

Ambulatory Surgery Center

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018

Base year - 2019

Forecast period - 2020 to 2027

Target Audience of the Global Neuralgia Treatment Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
    • 1.2.1. Neuralgia Treatment Market, by Region, 2018-2027 (USD Billion)
    • 1.2.2. Neuralgia Treatment Market, by Treatment, 2018-2027 (USD Billion)
    • 1.2.3. Neuralgia Treatment Market, by End-User, 2018-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Neuralgia Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Neuralgia Treatment Market Dynamics

  • 3.1. Neuralgia Treatment Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Neuralgia Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Neuralgia Treatment Market, by Treatment

  • 5.1. Market Snapshot
  • 5.2. Global Neuralgia Treatment Market by Treatment, Performance - Potential Analysis
  • 5.3. Global Neuralgia Treatment Market Estimates & Forecasts by Treatment 2017-2027 (USD Billion)
  • 5.4. Neuralgia Treatment Market, Sub Segment Analysis
    • 5.4.1. Drug Based
    • 5.4.2. Surgery

Chapter 6. Global Neuralgia Treatment Market, by End-User

  • 6.1. Market Snapshot
  • 6.2. Global Neuralgia Treatment Market by End-User - Potential Analysis
  • 6.3. Global Neuralgia Treatment Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
  • 6.4. Neuralgia Treatment Market, Sub Segment Analysis
    • 6.4.1. Hospitals & Clinics
    • 6.4.2. Ambulatory Surgery Center
    • 6.4.3. Others

Chapter 7. Global Neuralgia Treatment Market, Regional Analysis

  • 7.1. Neuralgia Treatment Market, Regional Market Snapshot
  • 7.2. North America Neuralgia Treatment Market
    • 7.2.1. U.S. Neuralgia Treatment Market
      • 7.2.1.1. Treatment breakdown estimates & forecasts, 2017-2027
      • 7.2.1.2. End-User breakdown estimates & forecasts, 2017-2027
    • 7.2.2. Canada Neuralgia Treatment Market
  • 7.3. Europe Neuralgia Treatment Market Snapshot
    • 7.3.1. U.K. Neuralgia Treatment Market
    • 7.3.2. Germany Neuralgia Treatment Market
    • 7.3.3. France Neuralgia Treatment Market
    • 7.3.4. Spain Neuralgia Treatment Market
    • 7.3.5. Italy Neuralgia Treatment Market
    • 7.3.6. Rest of Europe Neuralgia Treatment Market
  • 7.4. Asia-Pacific Neuralgia Treatment Market Snapshot
    • 7.4.1. China Neuralgia Treatment Market
    • 7.4.2. India Neuralgia Treatment Market
    • 7.4.3. Japan Neuralgia Treatment Market
    • 7.4.4. Australia Neuralgia Treatment Market
    • 7.4.5. South Korea Neuralgia Treatment Market
    • 7.4.6. Rest of Asia Pacific Neuralgia Treatment Market
  • 7.5. Latin America Neuralgia Treatment Market Snapshot
    • 7.5.1. Brazil Neuralgia Treatment Market
    • 7.5.2. Mexico Neuralgia Treatment Market
  • 7.6. Rest of The World Neuralgia Treatment Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. GlaxoSmithKline PLC
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Pfizer Inc.
    • 8.2.3. Novartis AG
    • 8.2.4. Biogen Inc.
    • 8.2.5. Cadila Healthcare Limited
    • 8.2.6. Lundbeck Pharmaceuticals LLC
    • 8.2.7. Allergan Plc
    • 8.2.8. Merz Pharma GmbH & Co.
    • 8.2.9. Trigemina Inc.,
    • 8.2.10. Abbott Laboratories

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.